PCVXVaxcyte, Inc.

$61.07

Who owns PCVX

328 institutions reported holding PCVX for 2026Q1, together 116% of the company, more than the 289 a quarter earlier.

328

Institutions reporting a position · as of 2026Q1 · up from 289 the quarter before

Shares held by institutions
162.5M

Shares held by institutions · 116% of the company · long US equity positions only, as reported on Form 13F

Reported value
$9.43B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
61 / 28

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
24
New positions
61
Positions exited
28
Added to
123
Reduced
75
Institutional ownership by quarter, 2020Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1328162.5M$9.43B
2025Q4289147.5M$6.81B
2025Q3281141.2M$5.09B
2025Q2287147.4M$4.79B
2025Q1311145.9M$5.88B
2024Q4320140.6M$11.5B
2024Q3323136.3M$15.6B
2024Q2261122.4M$9.25B
2024Q1249119.1M$8.13B
2023Q4222103.0M$6.47B
2023Q3200101.3M$5.16B
2023Q2195100.0M$4.99B
2023Q118584.1M$3.15B
2022Q419681.5M$3.91B
2022Q312456.5M$1.36B
2022Q210651.4M$1.12B
Largest reported holders, 2026Q1
HolderShares% of companyValue
HENDERSON GROUP PLC16.6Mn/a$960M
FMR LLC16.5Mn/a$958M
VANGUARD GROUP INC13.6Mn/a$791M
T. Rowe Price Investment Management, Inc.12.1Mn/a$705M
RA CAPITAL MANAGEMENT, L.P.11.5Mn/a$667M
BlackRock Inc.11.0Mn/a$638M
WELLINGTON MANAGEMENT GROUP LLP5.6Mn/a$326M
Paradigm Biocapital Advisors LP4.8Mn/a$279M
STATE STREET CORP4.4Mn/a$258M
Deep Track Capital, LP4.3Mn/a$250M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…